AV-078
- Generic Name
- AV-078
Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Aeovian Pharmaceuticals, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT06205381
- Locations
- 🇦🇺
Q-Pharm, Herston, Queensland, Australia
🇦🇺Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath